Celularity (CELUW) Other Working Capital Changes (2019 - 2025)
Celularity (CELUW) reported Other Working Capital Changes of $92000.0 for Q4 2025, down 5.15% year-over-year from $97000.0 in Q4 2024, and up 3.37% quarter-over-quarter from $89000.0 in Q3 2025.
Celularity (CELUW) Other Working Capital Changes (2019 - 2025) Analysis & Trends
Celularity (CELUW) has 7 years of Other Working Capital Changes data on file, last reported at $92000.0 in Q4 2025.
- Other Working Capital Changes for Q4 2025 came in at $92000.0, down 5.15% year-over-year; the trailing twelve-month figure through Dec 2025 was $350000.0 (down 5.66% YoY), and the FY2025 annual result was $350000.0, down 5.66% from the prior year.
- Other Working Capital Changes grew to $92000.0 in Q4 2025 per CELUW's latest filing, from $89000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $3.5 million in Q4 2023 and troughed at -$9.9 million in Q4 2021.
- A 5-year average of -$304800.0 and a median of $58500.0 in 2023 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 11907.83% in 2021 and fell as far as 2325.04% in 2021.
- A 5-year view of Other Working Capital Changes shows it stood at -$9.9 million in 2021, then soared by 105.52% to $547000.0 in 2022, then surged by 547.17% to $3.5 million in 2023, then tumbled by 97.26% to $97000.0 in 2024, then fell by 5.15% to $92000.0 in 2025.
- Business Quant data shows CELUW's Other Working Capital Changes at $92000.0 in Q4 2025, $89000.0 in Q3 2025, and $144000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Celularity | - | - | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 92,000.00 |
| Dec 31, 2025 | 92,000.00 |
| Sep 30, 2025 | 89,000.00 |
| Sep 30, 2025 | 89,000.00 |
| Jun 30, 2025 | 144,000.00 |
| Jun 30, 2025 | 144,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Mar 31, 2025 | 25,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Dec 31, 2024 | 97,000.00 |
| Sep 30, 2024 | 1.12 Mn |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | -556,000.00 |
| Jun 30, 2024 | -556,000.00 |
| Mar 31, 2024 | -294,000.00 |
| Mar 31, 2024 | -294,000.00 |
| Dec 31, 2023 | 3.54 Mn |
| Dec 31, 2023 | 3.54 Mn |
| Sep 30, 2023 | -2.13 Mn |
| Sep 30, 2023 | -2.13 Mn |